DOJ Takes Aim At Actavis' Drug-Making Practices
By Erin Coe · November 17, 2008, 12:00 AM EST
The U.S. Department of Justice has targeted two U.S. subsidiaries of Iceland-based generic-drug maker Actavis Group in a suit alleging that a series of regulatory inspections have turned up problems with...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login